Title: CCL21 as a potential biomarker for pulmonary arterial hypertension in systemic sclerosis
Abstract: Arthritis & RheumatologyVolume 71, Issue 4 p. 655-656 Letters Reply Anna-Maria Hoffmann-Vold MD, PhD, Anna-Maria Hoffmann-Vold MD, PhD Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, NorwaySearch for more papers by this authorHenriette Didriksen MS, Henriette Didriksen MS Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, NorwaySearch for more papers by this authorØyvind Molberg MD, PhD, Øyvind Molberg MD, PhD Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, NorwaySearch for more papers by this author Anna-Maria Hoffmann-Vold MD, PhD, Anna-Maria Hoffmann-Vold MD, PhD Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, NorwaySearch for more papers by this authorHenriette Didriksen MS, Henriette Didriksen MS Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, NorwaySearch for more papers by this authorØyvind Molberg MD, PhD, Øyvind Molberg MD, PhD Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, NorwaySearch for more papers by this author First published: 21 January 2019 https://doi.org/10.1002/art.40816Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume71, Issue4April 2019Pages 655-656 RelatedInformation